SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4p5w'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZR_A_H4BA760_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	VAL A 264 VAL A 255 PHE A 273 GLU A 268	None	1.25A	1zzrA-4p5wA: undetectable 1zzrB-4p5wA: undetectable	1zzrA-4p5wA: 21.12 1zzrB-4p5wA: 21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZR_B_H4BB761_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	PHE A 273 GLU A 268 VAL A 264 VAL A 255	None	1.24A	1zzrA-4p5wA: undetectable 1zzrB-4p5wA: undetectable	1zzrA-4p5wA: 21.12 1zzrB-4p5wA: 21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_A_H4BA760_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	VAL A 264 VAL A 255 PHE A 273 GLU A 268	None	1.21A	1zzuA-4p5wA: undetectable 1zzuB-4p5wA: undetectable	1zzuA-4p5wA: 21.12 1zzuB-4p5wA: 21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_B_H4BB761_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	PHE A 273 GLU A 268 VAL A 264 VAL A 255	None	1.24A	1zzuA-4p5wA: undetectable 1zzuB-4p5wA: undetectable	1zzuA-4p5wA: 21.12 1zzuB-4p5wA: 21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_C_VIAC903_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	5 / 12	LEU A 195 LEU A 203 ALA A 205 ALA A 276 PHE A 223	None	0.76A	2h42C-4p5wA: undetectable	2h42C-4p5wA: 22.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YK1_H_NCTH300_1 (FAB FRAGMENT, HEAVY CHAIN FAB FRAGMENT, LIGHT CHAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	5 / 10	ILE A 73 GLY A 63 VAL A 64 TYR A 640 ALA A 643	None	1.33A	2yk1H-4p5wA: undetectable 2yk1L-4p5wA: undetectable	2yk1H-4p5wA: 18.69 2yk1L-4p5wA: 17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DQR_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	VAL A 264 VAL A 255 PHE A 273 GLU A 268	None	1.25A	3dqrA-4p5wA: undetectable 3dqrB-4p5wA: undetectable	3dqrA-4p5wA: 20.91 3dqrB-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DQR_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	PHE A 273 GLU A 268 VAL A 264 VAL A 255	None	1.30A	3dqrA-4p5wA: undetectable 3dqrB-4p5wA: undetectable	3dqrA-4p5wA: 20.91 3dqrB-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX2_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	VAL A 264 VAL A 255 PHE A 273 GLU A 268	None	1.24A	3jx2A-4p5wA: undetectable 3jx2B-4p5wA: undetectable	3jx2A-4p5wA: 20.91 3jx2B-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX2_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	PHE A 273 GLU A 268 VAL A 264 VAL A 255	None	1.23A	3jx2A-4p5wA: undetectable 3jx2B-4p5wA: undetectable	3jx2A-4p5wA: 20.91 3jx2B-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX3_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	VAL A 264 VAL A 255 PHE A 273 GLU A 268	None	1.23A	3jx3A-4p5wA: undetectable 3jx3B-4p5wA: undetectable	3jx3A-4p5wA: 20.91 3jx3B-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX3_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	PHE A 273 GLU A 268 VAL A 264 VAL A 255	None	1.24A	3jx3A-4p5wA: undetectable 3jx3B-4p5wA: undetectable	3jx3A-4p5wA: 20.91 3jx3B-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX4_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	PHE A 273 GLU A 268 VAL A 264 VAL A 255	None	1.22A	3jx4A-4p5wA: undetectable 3jx4B-4p5wA: undetectable	3jx4A-4p5wA: 20.91 3jx4B-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX5_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	VAL A 264 VAL A 255 PHE A 273 GLU A 268	None	1.22A	3jx5A-4p5wA: undetectable 3jx5B-4p5wA: undetectable	3jx5A-4p5wA: 20.91 3jx5B-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX5_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	PHE A 273 GLU A 268 VAL A 264 VAL A 255	None	1.21A	3jx5A-4p5wA: undetectable 3jx5B-4p5wA: undetectable	3jx5A-4p5wA: 20.91 3jx5B-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX6_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	VAL A 264 VAL A 255 PHE A 273 GLU A 268	None	1.19A	3jx6A-4p5wA: undetectable 3jx6B-4p5wA: undetectable	3jx6A-4p5wA: 20.91 3jx6B-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX6_B_H4BB761_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	PHE A 273 GLU A 268 VAL A 264 VAL A 255	None	1.21A	3jx6A-4p5wA: undetectable 3jx6B-4p5wA: undetectable	3jx6A-4p5wA: 20.91 3jx6B-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_H_TFPH202_1 (PROTEIN S100-A4)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	5 / 12	LEU A 72 PHE A 34 ILE A 27 PHE A 21 PHE A 78	None	1.39A	3ko0G-4p5wA: 4.5 3ko0H-4p5wA: 4.3 3ko0I-4p5wA: 5.4 3ko0J-4p5wA: 5.3	3ko0G-4p5wA: 13.79 3ko0H-4p5wA: 13.79 3ko0I-4p5wA: 13.79 3ko0J-4p5wA: 13.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N61_A_H4BA760_1 (NITRIC OXIDE SYNTHASE)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 6	VAL A 264 VAL A 255 PHE A 273 GLU A 268	None	1.21A	3n61A-4p5wA: undetectable 3n61B-4p5wA: undetectable	3n61A-4p5wA: 20.91 3n61B-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N61_B_H4BB760_1 (NITRIC OXIDE SYNTHASE)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	PHE A 273 GLU A 268 VAL A 264 VAL A 255	None	1.18A	3n61A-4p5wA: undetectable 3n61B-4p5wA: undetectable	3n61A-4p5wA: 20.91 3n61B-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLJ_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	VAL A 264 VAL A 255 PHE A 273 GLU A 268	None	1.18A	3nljA-4p5wA: undetectable 3nljB-4p5wA: undetectable	3nljA-4p5wA: 20.91 3nljB-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLJ_B_H4BB761_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	PHE A 273 GLU A 268 VAL A 264 VAL A 255	None	1.21A	3nljA-4p5wA: undetectable 3nljB-4p5wA: undetectable	3nljA-4p5wA: 20.91 3nljB-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLP_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	VAL A 264 VAL A 255 PHE A 273 GLU A 268	None	1.23A	3nlpA-4p5wA: undetectable 3nlpB-4p5wA: undetectable	3nlpA-4p5wA: 20.91 3nlpB-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLP_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	PHE A 273 GLU A 268 VAL A 264 VAL A 255	None	1.28A	3nlpA-4p5wA: undetectable 3nlpB-4p5wA: undetectable	3nlpA-4p5wA: 20.91 3nlpB-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLQ_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 8	VAL A 264 VAL A 255 PHE A 273 GLU A 268	None	1.19A	3nlqA-4p5wA: undetectable 3nlqB-4p5wA: undetectable	3nlqA-4p5wA: 20.91 3nlqB-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLQ_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	PHE A 273 GLU A 268 VAL A 264 VAL A 255	None	1.17A	3nlqA-4p5wA: undetectable 3nlqB-4p5wA: undetectable	3nlqA-4p5wA: 20.91 3nlqB-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLR_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	VAL A 264 VAL A 255 PHE A 273 GLU A 268	None	1.22A	3nlrA-4p5wA: undetectable 3nlrB-4p5wA: undetectable	3nlrA-4p5wA: 20.91 3nlrB-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX3_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	VAL A 264 VAL A 255 PHE A 273 GLU A 268	None	1.23A	4cx3A-4p5wA: undetectable 4cx3B-4p5wA: undetectable	4cx3A-4p5wA: 20.91 4cx3B-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX3_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	PHE A 273 GLU A 268 VAL A 264 VAL A 255	None	1.24A	4cx3A-4p5wA: undetectable 4cx3B-4p5wA: undetectable	4cx3A-4p5wA: 20.91 4cx3B-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX4_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	VAL A 264 VAL A 255 PHE A 273 GLU A 268	None	1.26A	4cx4A-4p5wA: undetectable 4cx4B-4p5wA: undetectable	4cx4A-4p5wA: 20.91 4cx4B-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX4_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	PHE A 273 GLU A 268 VAL A 264 VAL A 255	None	1.25A	4cx4A-4p5wA: undetectable 4cx4B-4p5wA: undetectable	4cx4A-4p5wA: 20.91 4cx4B-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OKX_A_198A1002_1 (ANDROGEN RECEPTOR)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	5 / 12	LEU A 272 MET A 285 VAL A 249 MET A 230 VAL A 264	None	1.06A	4okxA-4p5wA: undetectable	4okxA-4p5wA: 18.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OKX_A_198A1002_1 (ANDROGEN RECEPTOR)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	5 / 12	LEU A 287 LEU A 272 VAL A 249 MET A 230 VAL A 264	None	1.35A	4okxA-4p5wA: undetectable	4okxA-4p5wA: 18.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ADD_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	PHE A 273 GLU A 268 VAL A 264 VAL A 255	None	1.24A	5addA-4p5wA: undetectable 5addB-4p5wA: undetectable	5addA-4p5wA: 20.91 5addB-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ADE_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	PHE A 273 GLU A 268 VAL A 264 VAL A 255	None	1.20A	5adeA-4p5wA: undetectable 5adeB-4p5wA: undetectable	5adeA-4p5wA: 20.91 5adeB-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G0P_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	VAL A 264 VAL A 255 PHE A 273 GLU A 268	None	1.22A	5g0pA-4p5wA: undetectable 5g0pB-4p5wA: undetectable	5g0pA-4p5wA: 20.91 5g0pB-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G0P_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 7	PHE A 273 GLU A 268 VAL A 264 VAL A 255	None	1.23A	5g0pA-4p5wA: undetectable 5g0pB-4p5wA: undetectable	5g0pA-4p5wA: 20.91 5g0pB-4p5wA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VLM_G_CVIG301_0 (REGULATORY PROTEIN TETR)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	5 / 12	ALA A 294 LEU A 272 ILE A 271 VAL A 199 ASP A 277	None	1.24A	5vlmG-4p5wA: undetectable	5vlmG-4p5wA: 19.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XXI_A_LSNA501_2 (CYTOCHROME P450 2C9)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	4 / 4	PHE A 151 LEU A 60 LEU A 656 VAL A 64	None	1.31A	5xxiA-4p5wA: undetectable	5xxiA-4p5wA: 19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DJZ_A_GMJA301_0 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	5 / 12	ILE A 650 PHE A 99 THR A 119 VAL A 115 LEU A 45	None	1.10A	6djzA-4p5wA: undetectable	6djzA-4p5wA: 19.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DJZ_B_GMJB301_0 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	5 / 12	ILE A 650 PHE A 99 THR A 119 VAL A 115 LEU A 45	None	1.26A	6djzB-4p5wA: undetectable	6djzB-4p5wA: 19.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EBP_A_DAHA123_0 (RIBONUCLEOSIDE-DIPHO SPHATE REDUCTASE, BETA SUBUNIT)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	5 / 9	THR A 265 GLY A 222 ILE A 271 PHE A 254 ILE A 233	None	0.95A	6ebpA-4p5wA: undetectable	6ebpA-4p5wA: 11.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EBP_B_DAHB123_0 (RIBONUCLEOSIDE-DIPHO SPHATE REDUCTASE, BETA SUBUNIT)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	5 / 10	THR A 265 GLY A 222 ILE A 271 PHE A 254 ILE A 233	None	0.94A	6ebpB-4p5wA: undetectable	6ebpB-4p5wA: 11.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EBP_C_DAHC123_0 (RIBONUCLEOSIDE-DIPHO SPHATE REDUCTASE, BETA SUBUNIT)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	5 / 10	THR A 265 GLY A 222 ILE A 271 PHE A 254 ILE A 233	None	0.95A	6ebpC-4p5wA: undetectable	6ebpC-4p5wA: 11.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EBZ_A_DAHA123_0 (RIBONUCLEOSIDE-DIPHO SPHATE REDUCTASE, BETA SUBUNIT)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	5 / 11	THR A 265 GLY A 222 ILE A 271 PHE A 254 ILE A 233	None	0.93A	6ebzA-4p5wA: undetectable	6ebzA-4p5wA: 11.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EBZ_B_DAHB123_0 (RIBONUCLEOSIDE-DIPHO SPHATE REDUCTASE, BETA SUBUNIT)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	5 / 11	THR A 265 GLY A 222 ILE A 271 PHE A 254 ILE A 233	None	0.92A	6ebzB-4p5wA: undetectable	6ebzB-4p5wA: 11.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EBZ_C_DAHC123_0 (RIBONUCLEOSIDE-DIPHO SPHATE REDUCTASE, BETA SUBUNIT)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	5 / 11	THR A 265 GLY A 222 ILE A 271 PHE A 254 ILE A 233	None	0.95A	6ebzC-4p5wA: undetectable	6ebzC-4p5wA: 11.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EBZ_D_DAHD123_0 (RIBONUCLEOSIDE-DIPHO SPHATE REDUCTASE, BETA SUBUNIT)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	5 / 11	THR A 265 GLY A 222 ILE A 271 PHE A 254 ILE A 233	None	0.92A	6ebzD-4p5wA: undetectable	6ebzD-4p5wA: 11.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GP2_A_DAHA126_0 (RIBONUCLEOSIDE-DIPHO SPHATE REDUCTASE BETA CHAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	5 / 11	THR A 265 GLY A 222 ILE A 271 PHE A 254 ILE A 233	None	0.96A	6gp2A-4p5wA: undetectable	6gp2A-4p5wA: 12.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GP2_B_DAHB126_0 (RIBONUCLEOSIDE-DIPHO SPHATE REDUCTASE BETA CHAIN)	4p5w	CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BIND ING MITOCHONDRIAL CARRIER PROTEIN ARALAR2 (Homo sapiens)	5 / 11	THR A 265 GLY A 222 ILE A 271 PHE A 254 ILE A 233	None	0.99A	6gp2B-4p5wA: undetectable	6gp2B-4p5wA: 12.40

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1ZZR_A_H4BA760_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"VAL A 264;VAL A 255;PHE A 273;GLU A 268","None","1.25A","1zzrA-4p5wA:undetectable;1zzrB-4p5wA:undetectable","1zzrA-4p5wA:21.12;1zzrB-4p5wA:21.12"],["1ZZR_B_H4BB761_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"PHE A 273;GLU A 268;VAL A 264;VAL A 255","None","1.24A","1zzrA-4p5wA:undetectable;1zzrB-4p5wA:undetectable","1zzrA-4p5wA:21.12;1zzrB-4p5wA:21.12"],["1ZZU_A_H4BA760_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"VAL A 264;VAL A 255;PHE A 273;GLU A 268","None","1.21A","1zzuA-4p5wA:undetectable;1zzuB-4p5wA:undetectable","1zzuA-4p5wA:21.12;1zzuB-4p5wA:21.12"],["1ZZU_B_H4BB761_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"PHE A 273;GLU A 268;VAL A 264;VAL A 255","None","1.24A","1zzuA-4p5wA:undetectable;1zzuB-4p5wA:undetectable","1zzuA-4p5wA:21.12;1zzuB-4p5wA:21.12"],["2H42_C_VIAC903_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",5,"LEU A 195;LEU A 203;ALA A 205;ALA A 276;PHE A 223","None","0.76A","2h42C-4p5wA:undetectable","2h42C-4p5wA:22.77"],["2YK1_H_NCTH300_1","FAB FRAGMENT, HEAVY CHAIN;FAB FRAGMENT, LIGHT CHAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",5,"ILE A  73;GLY A  63;VAL A  64;TYR A 640;ALA A 643","None","1.33A","2yk1H-4p5wA:undetectable;2yk1L-4p5wA:undetectable","2yk1H-4p5wA:18.69;2yk1L-4p5wA:17.41"],["3DQR_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"VAL A 264;VAL A 255;PHE A 273;GLU A 268","None","1.25A","3dqrA-4p5wA:undetectable;3dqrB-4p5wA:undetectable","3dqrA-4p5wA:20.91;3dqrB-4p5wA:20.91"],["3DQR_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"PHE A 273;GLU A 268;VAL A 264;VAL A 255","None","1.30A","3dqrA-4p5wA:undetectable;3dqrB-4p5wA:undetectable","3dqrA-4p5wA:20.91;3dqrB-4p5wA:20.91"],["3JX2_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"VAL A 264;VAL A 255;PHE A 273;GLU A 268","None","1.24A","3jx2A-4p5wA:undetectable;3jx2B-4p5wA:undetectable","3jx2A-4p5wA:20.91;3jx2B-4p5wA:20.91"],["3JX2_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"PHE A 273;GLU A 268;VAL A 264;VAL A 255","None","1.23A","3jx2A-4p5wA:undetectable;3jx2B-4p5wA:undetectable","3jx2A-4p5wA:20.91;3jx2B-4p5wA:20.91"],["3JX3_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"VAL A 264;VAL A 255;PHE A 273;GLU A 268","None","1.23A","3jx3A-4p5wA:undetectable;3jx3B-4p5wA:undetectable","3jx3A-4p5wA:20.91;3jx3B-4p5wA:20.91"],["3JX3_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"PHE A 273;GLU A 268;VAL A 264;VAL A 255","None","1.24A","3jx3A-4p5wA:undetectable;3jx3B-4p5wA:undetectable","3jx3A-4p5wA:20.91;3jx3B-4p5wA:20.91"],["3JX4_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"PHE A 273;GLU A 268;VAL A 264;VAL A 255","None","1.22A","3jx4A-4p5wA:undetectable;3jx4B-4p5wA:undetectable","3jx4A-4p5wA:20.91;3jx4B-4p5wA:20.91"],["3JX5_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"VAL A 264;VAL A 255;PHE A 273;GLU A 268","None","1.22A","3jx5A-4p5wA:undetectable;3jx5B-4p5wA:undetectable","3jx5A-4p5wA:20.91;3jx5B-4p5wA:20.91"],["3JX5_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"PHE A 273;GLU A 268;VAL A 264;VAL A 255","None","1.21A","3jx5A-4p5wA:undetectable;3jx5B-4p5wA:undetectable","3jx5A-4p5wA:20.91;3jx5B-4p5wA:20.91"],["3JX6_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"VAL A 264;VAL A 255;PHE A 273;GLU A 268","None","1.19A","3jx6A-4p5wA:undetectable;3jx6B-4p5wA:undetectable","3jx6A-4p5wA:20.91;3jx6B-4p5wA:20.91"],["3JX6_B_H4BB761_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"PHE A 273;GLU A 268;VAL A 264;VAL A 255","None","1.21A","3jx6A-4p5wA:undetectable;3jx6B-4p5wA:undetectable","3jx6A-4p5wA:20.91;3jx6B-4p5wA:20.91"],["3KO0_H_TFPH202_1","PROTEIN S100-A4;PROTEIN S100-A4;PROTEIN S100-A4;PROTEIN S100-A4","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",5,"LEU A  72;PHE A  34;ILE A  27;PHE A  21;PHE A  78","None","1.39A","3ko0G-4p5wA:4.5;3ko0H-4p5wA:4.3;3ko0I-4p5wA:5.4;3ko0J-4p5wA:5.3","3ko0G-4p5wA:13.79;3ko0H-4p5wA:13.79;3ko0I-4p5wA:13.79;3ko0J-4p5wA:13.79"],["3N61_A_H4BA760_1","NITRIC OXIDE SYNTHASE;NITRIC OXIDE SYNTHASE","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"VAL A 264;VAL A 255;PHE A 273;GLU A 268","None","1.21A","3n61A-4p5wA:undetectable;3n61B-4p5wA:undetectable","3n61A-4p5wA:20.91;3n61B-4p5wA:20.91"],["3N61_B_H4BB760_1","NITRIC OXIDE SYNTHASE;NITRIC OXIDE SYNTHASE","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"PHE A 273;GLU A 268;VAL A 264;VAL A 255","None","1.18A","3n61A-4p5wA:undetectable;3n61B-4p5wA:undetectable","3n61A-4p5wA:20.91;3n61B-4p5wA:20.91"],["3NLJ_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"VAL A 264;VAL A 255;PHE A 273;GLU A 268","None","1.18A","3nljA-4p5wA:undetectable;3nljB-4p5wA:undetectable","3nljA-4p5wA:20.91;3nljB-4p5wA:20.91"],["3NLJ_B_H4BB761_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"PHE A 273;GLU A 268;VAL A 264;VAL A 255","None","1.21A","3nljA-4p5wA:undetectable;3nljB-4p5wA:undetectable","3nljA-4p5wA:20.91;3nljB-4p5wA:20.91"],["3NLP_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"VAL A 264;VAL A 255;PHE A 273;GLU A 268","None","1.23A","3nlpA-4p5wA:undetectable;3nlpB-4p5wA:undetectable","3nlpA-4p5wA:20.91;3nlpB-4p5wA:20.91"],["3NLP_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"PHE A 273;GLU A 268;VAL A 264;VAL A 255","None","1.28A","3nlpA-4p5wA:undetectable;3nlpB-4p5wA:undetectable","3nlpA-4p5wA:20.91;3nlpB-4p5wA:20.91"],["3NLQ_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"VAL A 264;VAL A 255;PHE A 273;GLU A 268","None","1.19A","3nlqA-4p5wA:undetectable;3nlqB-4p5wA:undetectable","3nlqA-4p5wA:20.91;3nlqB-4p5wA:20.91"],["3NLQ_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"PHE A 273;GLU A 268;VAL A 264;VAL A 255","None","1.17A","3nlqA-4p5wA:undetectable;3nlqB-4p5wA:undetectable","3nlqA-4p5wA:20.91;3nlqB-4p5wA:20.91"],["3NLR_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"VAL A 264;VAL A 255;PHE A 273;GLU A 268","None","1.22A","3nlrA-4p5wA:undetectable;3nlrB-4p5wA:undetectable","3nlrA-4p5wA:20.91;3nlrB-4p5wA:20.91"],["4CX3_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"VAL A 264;VAL A 255;PHE A 273;GLU A 268","None","1.23A","4cx3A-4p5wA:undetectable;4cx3B-4p5wA:undetectable","4cx3A-4p5wA:20.91;4cx3B-4p5wA:20.91"],["4CX3_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"PHE A 273;GLU A 268;VAL A 264;VAL A 255","None","1.24A","4cx3A-4p5wA:undetectable;4cx3B-4p5wA:undetectable","4cx3A-4p5wA:20.91;4cx3B-4p5wA:20.91"],["4CX4_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"VAL A 264;VAL A 255;PHE A 273;GLU A 268","None","1.26A","4cx4A-4p5wA:undetectable;4cx4B-4p5wA:undetectable","4cx4A-4p5wA:20.91;4cx4B-4p5wA:20.91"],["4CX4_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"PHE A 273;GLU A 268;VAL A 264;VAL A 255","None","1.25A","4cx4A-4p5wA:undetectable;4cx4B-4p5wA:undetectable","4cx4A-4p5wA:20.91;4cx4B-4p5wA:20.91"],["4OKX_A_198A1002_1","ANDROGEN RECEPTOR","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",5,"LEU A 272;MET A 285;VAL A 249;MET A 230;VAL A 264","None","1.06A","4okxA-4p5wA:undetectable","4okxA-4p5wA:18.85"],["4OKX_A_198A1002_1","ANDROGEN RECEPTOR","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",5,"LEU A 287;LEU A 272;VAL A 249;MET A 230;VAL A 264","None","1.35A","4okxA-4p5wA:undetectable","4okxA-4p5wA:18.85"],["5ADD_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"PHE A 273;GLU A 268;VAL A 264;VAL A 255","None","1.24A","5addA-4p5wA:undetectable;5addB-4p5wA:undetectable","5addA-4p5wA:20.91;5addB-4p5wA:20.91"],["5ADE_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"PHE A 273;GLU A 268;VAL A 264;VAL A 255","None","1.20A","5adeA-4p5wA:undetectable;5adeB-4p5wA:undetectable","5adeA-4p5wA:20.91;5adeB-4p5wA:20.91"],["5G0P_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"VAL A 264;VAL A 255;PHE A 273;GLU A 268","None","1.22A","5g0pA-4p5wA:undetectable;5g0pB-4p5wA:undetectable","5g0pA-4p5wA:20.91;5g0pB-4p5wA:20.91"],["5G0P_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"PHE A 273;GLU A 268;VAL A 264;VAL A 255","None","1.23A","5g0pA-4p5wA:undetectable;5g0pB-4p5wA:undetectable","5g0pA-4p5wA:20.91;5g0pB-4p5wA:20.91"],["5VLM_G_CVIG301_0","REGULATORY PROTEIN TETR","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",5,"ALA A 294;LEU A 272;ILE A 271;VAL A 199;ASP A 277","None","1.24A","5vlmG-4p5wA:undetectable","5vlmG-4p5wA:19.51"],["5XXI_A_LSNA501_2","CYTOCHROME P450 2C9","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",4,"PHE A 151;LEU A  60;LEU A 656;VAL A  64","None","1.31A","5xxiA-4p5wA:undetectable","5xxiA-4p5wA:19.92"],["6DJZ_A_GMJA301_0","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",5,"ILE A 650;PHE A  99;THR A 119;VAL A 115;LEU A  45","None","1.10A","6djzA-4p5wA:undetectable","6djzA-4p5wA:19.66"],["6DJZ_B_GMJB301_0","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",5,"ILE A 650;PHE A  99;THR A 119;VAL A 115;LEU A  45","None","1.26A","6djzB-4p5wA:undetectable","6djzB-4p5wA:19.66"],["6EBP_A_DAHA123_0","RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE, BETA SUBUNIT","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",5,"THR A 265;GLY A 222;ILE A 271;PHE A 254;ILE A 233","None","0.95A","6ebpA-4p5wA:undetectable","6ebpA-4p5wA:11.47"],["6EBP_B_DAHB123_0","RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE, BETA SUBUNIT","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",5,"THR A 265;GLY A 222;ILE A 271;PHE A 254;ILE A 233","None","0.94A","6ebpB-4p5wA:undetectable","6ebpB-4p5wA:11.47"],["6EBP_C_DAHC123_0","RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE, BETA SUBUNIT","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",5,"THR A 265;GLY A 222;ILE A 271;PHE A 254;ILE A 233","None","0.95A","6ebpC-4p5wA:undetectable","6ebpC-4p5wA:11.47"],["6EBZ_A_DAHA123_0","RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE, BETA SUBUNIT","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",5,"THR A 265;GLY A 222;ILE A 271;PHE A 254;ILE A 233","None","0.93A","6ebzA-4p5wA:undetectable","6ebzA-4p5wA:11.47"],["6EBZ_B_DAHB123_0","RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE, BETA SUBUNIT","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",5,"THR A 265;GLY A 222;ILE A 271;PHE A 254;ILE A 233","None","0.92A","6ebzB-4p5wA:undetectable","6ebzB-4p5wA:11.47"],["6EBZ_C_DAHC123_0","RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE, BETA SUBUNIT","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",5,"THR A 265;GLY A 222;ILE A 271;PHE A 254;ILE A 233","None","0.95A","6ebzC-4p5wA:undetectable","6ebzC-4p5wA:11.47"],["6EBZ_D_DAHD123_0","RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE, BETA SUBUNIT","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",5,"THR A 265;GLY A 222;ILE A 271;PHE A 254;ILE A 233","None","0.92A","6ebzD-4p5wA:undetectable","6ebzD-4p5wA:11.47"],["6GP2_A_DAHA126_0","RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE BETA CHAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",5,"THR A 265;GLY A 222;ILE A 271;PHE A 254;ILE A 233","None","0.96A","6gp2A-4p5wA:undetectable","6gp2A-4p5wA:12.40"],["6GP2_B_DAHB126_0","RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE BETA CHAIN","4p5w","CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2,CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN ARALAR2","Homo sapiens",5,"THR A 265;GLY A 222;ILE A 271;PHE A 254;ILE A 233","None","0.99A","6gp2B-4p5wA:undetectable","6gp2B-4p5wA:12.40"]]